European Patent Granted for OPM’s OsteoFab 3D Printed Implants 3D Printing Processes
Oxford Performance Materials, Inc. (OPM), a leader in advanced materials science and high performance additive manufacturing (HPAM), today announced that it has received a Notice of Decision to Grant a Patent from the European Patent Office (EPO) for OPM’s invention on a “Customized Implant for Bone Replacement”, which leverages its OsteoFab implant manufacturing process, originally filed on December 5, 2011. The patent, which took effect on December 21, 2016, will be valid until August 7, 2029, and enables OPM to apply its high-performance additive manufacturing process to 3D print customized implants for bone replacement.